Scientific Sessions
  • #AHA22
  • Virtual Experience Access
  • Sessions Posters
  • Late-Breaking Science
  • Daily Coverage
  • Industry Highlights
  • Featured Exhibitors
  • Program
  • Previews
Topics
  • Late-Breaking Science
  • Daily Coverage
  • Industry Highlights
  • Featured Exhibitors
  • Program
  • Previews
Resources
  • #AHA22
  • Virtual Experience Access
  • Sessions Posters
User Tools
  • Privacy Policy
  • Terms & Conditions
  • Accessibility Statement
Twitter iconFacebook iconInstagram iconYouTube iconPinterest iconLinkedIn icon
Sep 30th, 2021

Frontiers in Science

On-demand sessions to focus on the latest breakthroughs and pre-publication discoveries.


Getty Images 1223789411

Frontiers in Science brings together early, mid- and senior investigators to debate the latest breakthroughs and pre-publication discoveries in the areas of arrythmia research, thrombosis and vascular disease.

All times are EST.  Refer to the Online Program Planner for more details.

Available OnDemand

8 a.m., Saturday, Nov. 13

Arteriosclerosis, Thrombosis, Vascular Biology
-       Frontiers in Thrombosis | Genetic and Molecular Mechanisms of Cardiovascular Calcification  
Electrophysiology and Arrhythmias
-       Arrhythmia Research Summit | Novel Therapies Targeting Arrhythmogenesis: Bringing the Bench to the Bedside 
-       Arrhythmia Research Summit | Clinical Applications of Multi-Omic Data 
-       Arrhythmia Research Summit | Translating Basic to Clinical Research in Atrial Fibrillation 
-       Arrhythmia Research Summit | Translational Research Targeting Ventricular Arrhythmias and Sudden Death 
-       Arrhythmia Research Summit | Arrhythmia Applications of Digital Health and Precision Medicine 
-      Arrhythmia Research Summit | Special Topics and Innovations in Arrhythmia Management  
Vascular Disease and Thrombosis
-        Frontiers in Vascular Disease | COVID-19 and Coagulopathy: Trailblazing Pathways to Prevention and Treatment
-       Frontiers in Vascular Disease | Everything Old Is New Again: Emerging Therapies for Thrombotic Disorders  


Interesting Stories
Modern Wearable Defibrillation
Sponsored by Kestra Medical Technologies
Modern Wearable Defibrillation
MiCare Path joins the AHA CHTI and will integrate AHA science-based
Sponsored by MiCare Path
MiCare Path joins the AHA CHTI and will integrate AHA science-based
Data-driven precision medicine
Sponsored by Tempus
Data-driven precision medicine
New Double Take Videos from NEJM
Sponsored by NEJM Group
New Double Take Videos from NEJM
More Content
Screenshot 2021 11 02 130142
Sponsored Content
Antiplatelet Therapy in Patients With Coronary Artery Disease and Acute Ischemic Stroke/Transient Ischemic Attack
Oct 4th, 2022
Getty Images 1180201381
Daily Coverage
Join the Scientific Sessions 2022 Scavenger Hunt
Aug 15th, 2022
Live Meeting Image
AHA21
Member Connect
Dec 13th, 2021
P104 Steven Botts Image
AHA21
Members Connect: ERG Governs Chromatin Accessibility in Aortic Endothelial Cells
Dec 13th, 2021
Pres Address Lloyd Jones2
AHA21
Watch: #AHA21 recap and look ahead
Nov 22nd, 2021
Getty Images 1301907602
AHA21
Mark your calendar for #AHA22
Nov 19th, 2021
Elaine Hylek, MD, MPH, and Bruno Caramelli, MD, PhD
AHA21
Trials’ results suggest advancements in treatment approaches for AF and insight on the cardiac effects of coffee consumption
Nov 19th, 2021
Lbs02 Group Blood Patel
AHA21
Update on local and global hypertension science
Nov 19th, 2021
Getty Images 1219980553 61849bc953192
AHA21
Read all about #AHA21 in your daily coverage
Nov 16th, 2021
(from left to right): Brahmajee K. Nallamothu, MD, MPH, FAHA, Rhoda Au, PhD, Seth Martin, MD, MHS, FAHA, and Andrea Beaton, MD, FAHA
AHA21
QCOR at Sessions: mHealth strategies could help treat CVD around the world
Nov 15th, 2021
(from left to right, top to bottom rows): Corey E. Ventetuolo, MD, MS, Magdi Yacoub, OM, FRS, Karen Joynt Maddox, MD, MPH, FAHA, Gregory Lewis, MD, Marco Guazzi, MD, PhD, FAHA, Ana Macumbi, MD, PhD, FESC, Mark T. Gladwin, MD, FAHA, and William Bain, MD
AHA21
The shifting profile of cardiopulmonary COVID-19 survivors
Nov 15th, 2021
(from left to right): Jonathan P. Piccini, MD, MHS, FAHA, and Steven A. Lubitz, MD, MPH, FAHA
AHA21
Late-Breaking Science: New information in cardiac disease
Nov 15th, 2021